- Home
- SANG vs PRME Comparison
SANG vs PRME Comparison
Compare SANG & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- PRME
- Stock Information
- Founded
- SANG 1984
- PRME 2019
- Country
- SANG Canada
- PRME United States
- Employees
- SANG N/A
- PRME N/A
- Industry
- SANG Computer Software: Programming Data Processing
- PRME Medicinal Chemicals and Botanical Products
- Sector
- SANG Technology
- PRME Health Care
- Exchange
- SANG Nasdaq
- PRME Nasdaq
- Market Cap
- SANG 189.6M
- PRME 191.7M
- IPO Year
- SANG 2021
- PRME 2022
- Fundamental
- Price
- SANG $6.00
- PRME $2.59
- Analyst Decision
- SANG
- PRME Buy
- Analyst Count
- SANG 0
- PRME 6
- Target Price
- SANG N/A
- PRME $9.38
- AVG Volume (30 Days)
- SANG 2.4K
- PRME 3.1M
- Earning Date
- SANG 05-08-2025
- PRME 08-04-2025
- Dividend Yield
- SANG N/A
- PRME N/A
- EPS Growth
- SANG N/A
- PRME N/A
- EPS
- SANG N/A
- PRME N/A
- Revenue
- SANG $238,264,000.00
- PRME $3,846,000.00
- Revenue This Year
- SANG N/A
- PRME $104.12
- Revenue Next Year
- SANG $2.91
- PRME $196.78
- P/E Ratio
- SANG N/A
- PRME N/A
- Revenue Growth
- SANG N/A
- PRME 550.76
- 52 Week Low
- SANG $4.08
- PRME $1.11
- 52 Week High
- SANG $7.99
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- SANG 62.63
- PRME 69.76
- Support Level
- SANG $5.61
- PRME $1.56
- Resistance Level
- SANG $5.96
- PRME $2.78
- Average True Range (ATR)
- SANG 0.09
- PRME 0.26
- MACD
- SANG 0.02
- PRME 0.08
- Stochastic Oscillator
- SANG 100.00
- PRME 76.81
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.